Skip to main content
Signal8

REVELATION BIOSCIENCES, INC. (REVB)

Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based enterprise was formerly known as Petra Acquisition, Inc., before officially adopting the name Revelation Biosciences, Inc. in January 2022.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Revelation Biosciences, Inc. logo

Revelation Biosciences, Inc.

NASDAQ:REVBHealthcare
AH-3.48%$3.74
Close$3.88+1.57%
Mkt Cap$2.65M
EV-
Float539K
O/S683K
VOL13K sh
$ Vol$50K
RVOL0.59×
Inst Own6.1%
SI2.4%
Net Cash/Sh-
Dilution
Revelation Biosciences, Inc. logoNASDAQ:REVBAH$3.74-3.48%
Short interest (FINRA)
2.4%
Oct 30 (19d)

Float 538.50K · Signal8 dilution snapshot · Nov 5, 2026

12.8K
Oct 30 (19d)prev 944▲ 1255.1%
1.00
Oct 30 (19d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow REVB shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
38.7%
Nov 16 (2d)prev 38.7%– 0.0 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

1
Oct 27 (22d)prev 273▼ 99.6%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver24 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 202612.8K sh
Oct 15, 2026944 sh
Sep 30, 2026226 sh
Sep 15, 202637 sh
Aug 31, 202683 sh
Latest fails to deliver
DateShares failed
Oct 27, 20261 sh
Oct 26, 2026273 sh
Oct 23, 2026423 sh
Oct 22, 2026496 sh
Oct 21, 202610.1K sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 16
Latest sessions
DateReported short
Nov 16, 202638.7%
Nov 13, 202638.7%
Nov 12, 202617.7%
Nov 11, 202635.4%
Nov 10, 20266.4%
90-session median 27.8%mean 30.5%range 0.5–73.2%

130 calendar days requested; 91 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for REVB: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 12,792 REVB shares were sold short (2.38% of a 539K-share float, 1.00 days to cover).